TAYLOR DAPHNE (SVP, CFO) exercised options at APTEVO THERAPEUTICS INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 2 exercises
Filed: 3/4/2025ACC: 0000950170-25-032183
Officer· SVP, CFO
Since Mar 2023
0.00
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
4
Total transactions
3.00 acquired · 3.00 disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+2.00
Price / share
—
Trade value
—
% of position
13.3%
3/2/2025
15.00→17.00
Common Stock
Direct
Shares
+1.00
Price / share
—
Trade value
—
% of position
5.9%
3/4/2025
17.00→18.00
Total
Net shares
+3.00
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/2/2025 | M · Option Exercise | +2.00 | — | — | 13.3% | 15.00 | 17.00 |
| Common Stock Direct | 3/4/2025 | M · Option Exercise | +1.00 | — | — | 5.9% | 17.00 | 18.00 |
| Total | +3.00 | $0.00 | ||||||
Derivative Transactions2
Restricted Stock Unit
Direct
Converts to
Common Stock
2.00 shares
Shares
−2.00
Strike price
Held after
2.00
Exercisable
—
3/2/2025
Restricted Stock Unit
Direct
Converts to
Common Stock
1.00 shares
Shares
−1.00
Strike price
Held after
0.00
Exercisable
—
3/4/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Unit Direct | Common Stock2.00 shares | 3/2/2025 | M · Option Exercise | −2.00 | — | 2.00 | |
| Restricted Stock Unit Direct | Common Stock1.00 shares | 3/4/2025 | M · Option Exercise | −1.00 | — | 0.00 |